Cohance Lifesciences Limited
COHANCE
Classement en actions
#6337
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Prix de l'action
$5.09
Capitalisation boursière
$1.95B
Changement (1 jour)
0.79%
Changement (1 an)
-57.04%
Pays
IN
Échange Cohance Lifesciences Limited (COHANCE)
Catégorie
Healthcare
Ratio P/B pour Cohance Lifesciences Limited (COHANCE)
Ratio P/B au October 2026 TTM : 22.54
Selon les derniers rapports financiers et le cours de l'action de Cohance Lifesciences Limited, le ratio cours/valeur comptable actuel (TTM) est 22.54. À la fin de 2024, le ratio P/B était de 8.31.
Historique du ratio P/B pour Cohance Lifesciences Limited de 2019 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 22.54 | 41.50% |
| 2025 | 15.93 | 91.72% |
| 2024 | 8.31 | 19.91% |
| 2023 | 6.93 | -32.77% |
| 2022 | 10.31 | -3.75% |
| 2021 | 10.71 | 253.56% |
| 2020 | 3.03 | -58.32% |
| 2019 | 7.27 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -77.64% |
IN
|
